Skip to content

Common Stock at other companies

HRO
HarrowHROW
50M0.0%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
200M0.0%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$22K+37.5%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6K+20.0%
Vera Therapeutics logo
Vera TherapeuticsVERA
$72K+12.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$0-100%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's common stock?
Kodiak Sciences Inc (KOD) reported common stock of $6K in Q1 2026.
How has Kodiak Sciences Inc's common stock changed year-over-year?
Kodiak Sciences Inc's common stock increased by 20.0% year-over-year, from $5K to $6K.
What is the long-term trend for Kodiak Sciences Inc's common stock?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's common stock has grown at a 3.7% compound annual growth rate (CAGR), from $5K to $6K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).